{"id":"https://openalex.org/W2902050182","doi":null,"title":"Preclinical radiation dose optimization, dosimetry and maximum tolerated dose studies of Lu-177-labeled CTT1403, a phosphoramidate-based PSMA inhibitor for targeted radionuclide therapy of prostate cancer.","display_name":"Preclinical radiation dose optimization, dosimetry and maximum tolerated dose studies of Lu-177-labeled CTT1403, a phosphoramidate-based PSMA inhibitor for targeted radionuclide therapy of prostate cancer.","publication_year":2018,"publication_date":"2018-05-01","ids":{"openalex":"https://openalex.org/W2902050182","mag":"2902050182"},"language":"en","primary_location":{"id":"mag:2902050182","doi":null,"is_oa":false,"landing_page_url":"https://jnm.snmjournals.org/content/59/supplement_1/135","pdf_url":null,"source":{"id":"https://openalex.org/S4210180780","display_name":"Journal of Nuclear Medicine","issn_l":"0161-5505","issn":["0161-5505","1535-5667","2159-662X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315767","host_organization_name":"Society of Nuclear Medicine and Molecular Imaging","host_organization_lineage":["https://openalex.org/P4310315767"],"host_organization_lineage_names":["Society of Nuclear Medicine and Molecular Imaging"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Journal of Nuclear Medicine","raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042835468","display_name":"Xiaoxi Ling","orcid":"https://orcid.org/0000-0002-6871-1955","observed_orcids":["https://orcid.org/0000-0002-6871-1955"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaoxi Ling","raw_affiliation_strings":["3University of Pittsburgh Pittsburgh PA United States"],"raw_orcid":"https://orcid.org/0000-0002-6871-1955","affiliations":[{"raw_affiliation_string":"3University of Pittsburgh Pittsburgh PA United States","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001429263","display_name":"Joseph D. Latoche","orcid":"https://orcid.org/0000-0002-4800-5623","observed_orcids":["https://orcid.org/0000-0002-4800-5623"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph D. Latoche","raw_affiliation_strings":["3University of Pittsburgh Pittsburgh PA United States"],"raw_orcid":"https://orcid.org/0000-0002-4800-5623","affiliations":[{"raw_affiliation_string":"3University of Pittsburgh Pittsburgh PA United States","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040489351","display_name":"Cindy J. Choy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093643","display_name":"Cancer Targeted Technology (United States)","ror":"https://ror.org/00k4pey18","country_code":"US","type":"company","lineage":["https://openalex.org/I4210093643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cindy J. Choy","raw_affiliation_strings":["1Cancer Targeted Technology Woodinville WA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Targeted Technology Woodinville WA United States","institution_ids":["https://openalex.org/I4210093643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075737095","display_name":"Jonathan J. Geruntho","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jonathan J. Geruntho","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007380954","display_name":"Charles M. Laymon","orcid":"https://orcid.org/0000-0002-5966-7219","observed_orcids":["https://orcid.org/0000-0002-5966-7219"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles M. Laymon","raw_affiliation_strings":["5Radiology University of Pittsburgh Pittsburgh PA United States"],"raw_orcid":"https://orcid.org/0000-0002-5966-7219","affiliations":[{"raw_affiliation_string":"5Radiology University of Pittsburgh Pittsburgh PA United States","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078939746","display_name":"Brenda F. Kurland","orcid":"https://orcid.org/0000-0002-5669-0595","observed_orcids":["https://orcid.org/0000-0002-5669-0595"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brenda F. Kurland","raw_affiliation_strings":["4Biostatistics University of Pittsburgh Pittsburgh PA United States"],"raw_orcid":"https://orcid.org/0000-0002-5669-0595","affiliations":[{"raw_affiliation_string":"4Biostatistics University of Pittsburgh Pittsburgh PA United States","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050816193","display_name":"Beatrice C. Langton-Webster","orcid":"https://orcid.org/0000-0001-7240-7684","observed_orcids":["https://orcid.org/0000-0001-7240-7684"]},"institutions":[{"id":"https://openalex.org/I4210093643","display_name":"Cancer Targeted Technology (United States)","ror":"https://ror.org/00k4pey18","country_code":"US","type":"company","lineage":["https://openalex.org/I4210093643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Beatrice Langton-Webster","raw_affiliation_strings":["1Cancer Targeted Technology Woodinville WA United States"],"raw_orcid":"https://orcid.org/0000-0001-7240-7684","affiliations":[{"raw_affiliation_string":"1Cancer Targeted Technology Woodinville WA United States","institution_ids":["https://openalex.org/I4210093643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036466625","display_name":"Clifford E. Berkman","orcid":"https://orcid.org/0000-0003-2544-5252","observed_orcids":["https://orcid.org/0000-0003-2544-5252"]},"institutions":[{"id":"https://openalex.org/I4210093643","display_name":"Cancer Targeted Technology (United States)","ror":"https://ror.org/00k4pey18","country_code":"US","type":"company","lineage":["https://openalex.org/I4210093643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Clifford E. Berkman","raw_affiliation_strings":["1Cancer Targeted Technology Woodinville WA United States"],"raw_orcid":"https://orcid.org/0000-0003-2544-5252","affiliations":[{"raw_affiliation_string":"1Cancer Targeted Technology Woodinville WA United States","institution_ids":["https://openalex.org/I4210093643"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002367405","display_name":"Carolyn J. Anderson","orcid":"https://orcid.org/0000-0002-5663-282X","observed_orcids":["https://orcid.org/0000-0002-5663-282X"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carolyn J. Anderson","raw_affiliation_strings":["3University of Pittsburgh Pittsburgh PA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3University of Pittsburgh Pittsburgh PA United States","institution_ids":["https://openalex.org/I170201317"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.15928177,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"59","issue":null,"first_page":"135","last_page":"135"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lutetium-177","display_name":"lutetium-177","score":0.7929999828338623},{"id":"https://openalex.org/keywords/phosphoramidate-prodrug","display_name":"phosphoramidate prodrug","score":0.8109999895095825},{"id":"https://openalex.org/keywords/psma-inhibitors","display_name":"PSMA inhibitors","score":0.925000011920929},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.8209999799728394},{"id":"https://openalex.org/keywords/targeted-radionuclide-therapy","display_name":"targeted radionuclide therapy","score":0.9769999980926514},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.6470000147819519},{"id":"https://openalex.org/keywords/dosimetry","display_name":"dosimetry","score":0.8059999942779541},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.9269999861717224},{"id":"https://openalex.org/keywords/dose-optimization","display_name":"dose optimization","score":0.5509999990463257},{"id":"https://openalex.org/keywords/nephrotoxicity","display_name":"nephrotoxicity","score":0.4950000047683716},{"id":"https://openalex.org/keywords/biodosimetry","display_name":"biological dosimetry","score":0.46700000762939453}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7800411581993103},{"id":"https://openalex.org/C75088862","wikidata":"https://www.wikidata.org/wiki/Q2291081","display_name":"Dosimetry","level":2,"score":0.7543284893035889},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.7531772255897522},{"id":"https://openalex.org/C2777807558","wikidata":"https://www.wikidata.org/wiki/Q4914764","display_name":"Biodistribution","level":3,"score":0.7182815074920654},{"id":"https://openalex.org/C2993559085","wikidata":"https://www.wikidata.org/wiki/Q2126444","display_name":"Radionuclide therapy","level":2,"score":0.6792410016059875},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.5623457431793213},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.48242196440696716},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.45657920837402344},{"id":"https://openalex.org/C149857219","wikidata":"https://www.wikidata.org/wiki/Q5239054","display_name":"Effective dose (radiation)","level":2,"score":0.45333701372146606},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.4209403395652771},{"id":"https://openalex.org/C2776146153","wikidata":"https://www.wikidata.org/wiki/Q7281276","display_name":"Radioimmunotherapy","level":4,"score":0.41466227173805237},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3617491126060486},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35313624143600464},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3230530321598053},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.1663701832294464},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.11637458205223083},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2902050182","doi":null,"is_oa":false,"landing_page_url":"https://jnm.snmjournals.org/content/59/supplement_1/135","pdf_url":null,"source":{"id":"https://openalex.org/S4210180780","display_name":"Journal of Nuclear Medicine","issn_l":"0161-5505","issn":["0161-5505","1535-5667","2159-662X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315767","host_organization_name":"Society of Nuclear Medicine and Molecular Imaging","host_organization_lineage":["https://openalex.org/P4310315767"],"host_organization_lineage_names":["Society of Nuclear Medicine and Molecular Imaging"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Journal of Nuclear Medicine","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8199999928474426}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2963700677","https://openalex.org/W2611673620","https://openalex.org/W4395461047","https://openalex.org/W1511130500","https://openalex.org/W7138870976","https://openalex.org/W2968654070","https://openalex.org/W4387137719","https://openalex.org/W2901253757","https://openalex.org/W4402713269","https://openalex.org/W4400412552"],"abstract_inverted_index":{"135":[0],"Objectives:":[2],"Prostate-specific":[6],"membrane":[7],"antigen":[8],"(PSMA)":[9],"has":[10],"proven":[11],"to":[12,35,134,137,157,172,200,224,264,290,305,322,360,380],"be":[13,291,361,381,418],"an":[14,69,79,146,297,387],"exceptional":[15],"biomarker":[16],"for":[17,155,179,195,222,232,375,449],"prostate":[18,27],"cancer":[19],"as":[20,183,185],"it":[21],"is":[22,49,333,396],"expressed":[23],"on":[24,102,217],"nearly":[25],"all":[26],"cancers,":[28],"and":[29,38,46,111,150,189,219,237,239,410,420,440,454,468],"increased":[30],"expression":[31],"correlates":[32],"with":[33,78,296,386],"progression":[34],"metastatic":[36],"disease":[37],"castration":[39],"resistance.":[40],"The":[41],"performance":[42],"of":[43,89,141,177,267,275,282,300,308,356,390,400,412,437,446,452],"PSMA-targeted":[44],"imaging":[45],"therapeutic":[47,87,254],"agents":[48],"often":[50],"limited":[51],"by":[52,430,472],"unfavorable":[53],"rapid":[54],"renal":[55],"clearance.":[56],"Previously,":[57],"we":[58,98],"developed":[59],"a":[60,92,192,207,306,319,431,441],"new":[61],"PSMA":[62,81],"targeted":[63],"radiotherapeutic":[64],"agent,":[65],"CTT1403,":[66],"which":[67,303,332],"contained":[68],"albumin":[70],"binding":[71],"motif":[72],"that":[73],"extends":[74],"blood":[75,234],"circulation":[76],"time":[77,169],"irreversible":[80],"inhibitor.":[82],"Building":[83],"upon":[84],"the":[85,122,161,202,250,268,280,283,288,292,314,342,364,371,382,401,407,434,444],"superior":[86],"efficacy":[88,409],"CTT1403":[90,103,142,178,214,261,276,357,413],"in":[91,104,128,191,258,311,325,363,393,422,465,470],"PSMA+":[93,365],"PC3-PIP":[94,366],"human":[95,204,367],"xenograft":[96,368],"model,":[97,369],"performed":[99],"translational":[100],"studies":[101],"rodent":[105],"models,":[106],"including":[107],"dose":[108,114,123,251,293,299,320,339,383],"optimization,":[109],"dosimetry,":[110],"maximum":[112],"tolerated":[113],"(MTD).":[115],"Methods:":[118],"For":[121],"optimization":[124,252],"study,":[125,163,209,253,316],"tumor-bearing":[126],"mice":[127,259,269,317],"treatment":[129,262],"groups":[130],"were":[131,165,187,211,229,256,358,463],"randomly":[132],"selected":[133],"receive":[135],"1":[136],"3":[138,273],"reduced":[139],"doses":[140,215,274,355],"or":[143,272,352],"put":[144],"into":[145],"untreated":[147],"control":[148],"group,":[149],"tumor":[151],"growth":[152],"was":[153,338,378,428],"monitored":[154,221],"up":[156,171,223],"120":[158],"days.":[159],"In":[160,206,249,313],"dosimetry":[162,196,343],"rats":[164,210],"euthanized":[166],"at":[167],"various":[168],"points":[170],"5":[173],"weeks":[174],"post":[175],"administration":[176,373,388],"biodistribution.":[180],"Their":[181],"organs":[182],"well":[184],"excretion":[186],"collected":[188,230],"counted":[190],"gamma":[193],"counter":[194],"analysis":[197],"using":[198],"OLINDA/EXM":[199],"estimate":[201],"equivalent":[203,321],"doses.":[205],"MTD":[208,315,403],"given":[212],"increasing":[213],"based":[216],"weight":[218],"closely":[220],"7":[225],"weeks.":[226],"Blood":[227],"samples":[228],"weekly":[231],"complete":[233],"count":[235],"(CBC)":[236],"liver":[238],"kidney":[240,289],"enzyme":[241],"analysis.":[242],"Results:":[245],"responses":[255],"observed":[257],"receiving":[260,270,318],"compared":[263],"controls.":[265],"Half":[266],"2":[271],"survived":[277],"longer":[278],"than":[279,335,398],"duration":[281],"study.":[284,344],"Dosimstry":[285],"data":[286],"demonstrate":[287],"limiting":[294,340,384],"organ,":[295,385],"effective":[298,362,421],"5.18":[301],"mSv/MBq,":[302],"corresponds":[304],"limit":[307,389],"4.4":[309,391],"GBq":[310,324,392],"humans.":[312,423],"10.5":[323],"humans":[326],"did":[327],"not":[328],"have":[329],"dose-limiting":[330],"toxicity,":[331],"more":[334],"twice":[336],"what":[337],"from":[341,433,443],"Conclusions:":[347],"Multiple":[350],"(2":[351],"3)":[353],"lower":[354],"found":[359,379],"extending":[370],"potential":[372],"options":[374],"CTT1403.":[376],"Kidney":[377],"humans;":[394],"this":[395,415,466],"less":[397],"half":[399],"estimated":[402],"(10.5":[404],"Gbq).":[405],"Overall,":[406],"preclinical":[408],"toxicity":[411],"suggests":[414],"agent":[416],"would":[417],"safe":[419],"Research":[424],"Support:":[425],"This":[426],"work":[427],"supported":[429,469],"contract":[432],"National":[435],"Institutes":[436],"Health":[438],"(HHSN261201500074C)":[439],"grant":[442],"Department":[445],"Energy":[447],"(DE-SC0008833)":[448],"partial":[450],"support":[451],"JJG":[453],"XL.":[455],"UPCI":[456],"shared":[457],"resources":[458],"(In":[459],"Vivo":[460],"Imaging":[461],"Facility)":[462],"used":[464],"research":[467],"part":[471],"NCI":[473],"P30CA047904.":[474]},"counts_by_year":[],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2018-12-11T00:00:00"}